Literature DB >> 24324082

Epithelial-mesenchymal transition and cancer stem cells in endometrial cancer.

Anna Supernat1, Sylwia Lapinska-Szumczyk, Hanna Majewska, Jacek Gulczynski, Wojciech Biernat, Dariusz Wydra, Anna J Zaczek.   

Abstract

BACKGROUND/AIM: Epithelial-mesenchymal transition (EMT) and cancer stem cells (CSCs) are presumed to be key conditions for malignancy. Data concerning their role in endometrial cancer (EC) are scarce. We aimed to investigate the possible link between EMT and CSCs markers in EC samples.
MATERIALS AND METHODS: The study encompassed 156 primary tumour samples. Using RT-qPCR, we analyzed the expression of EMT-related genes, SNAIL and SLUG, and the CSCs marker CD133.
RESULTS: SNAIL and SLUG correlated with each other (R=0.33; p=0.00003). All the studied genes were expressed in both normal and malignant endometrial tissue. Decreased SNAIL expression was found to correlate with post-menopausal status (p=0.002). Decreased SLUG expression was associated with shorter overall survival (p=0.01).
CONCLUSION: SLUG expression could serve as a prognostic factor in EC. No correlation between the expression of EMT and CSCs markers was found, suggesting there to be no association between the EMT and CSC phenotype in endometrial cancer.

Entities:  

Keywords:  Epithelial-mesenchymal transition; cancer stem cells; endometrial cancer; molecular markers; quantitative PCR

Mesh:

Substances:

Year:  2013        PMID: 24324082

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Slug and CD133 expression are associated with peritoneal carcinomatosis and survival in gastric cancer.

Authors:  Joori Kim; Kabsoo Shin; Sung Hak Lee; In-Ho Kim
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 2.  Control of cancer formation by intrinsic genetic noise and microenvironmental cues.

Authors:  Amy Brock; Silva Krause; Donald E Ingber
Journal:  Nat Rev Cancer       Date:  2015-07-09       Impact factor: 60.716

Review 3.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

4.  MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.

Authors:  Ping Chen; Tianrong Xing; Qingdong Wang; Ai Liu; Haiping Liu; Yuhong Hu; Yanjia Ji; Ying Song; Dongwei Wang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

5.  Selection of reference genes for measuring the expression of aiiO in Ochrobactrum quorumnocens A44 using RT-qPCR.

Authors:  Dorota M Krzyżanowska; Anna Supernat; Tomasz Maciąg; Marta Matuszewska; Sylwia Jafra
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

6.  MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3.

Authors:  Ping Liu; Chao Wang; Chengbin Ma; Qiongwei Wu; Wenying Zhang; Guoying Lao
Journal:  Cancer Cell Int       Date:  2016-09-05       Impact factor: 5.722

7.  Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas.

Authors:  Salvatore Lopez; Emanuele Perrone; Stefania Bellone; Elena Bonazzoli; Burak Zeybek; Chanhee Han; Joan Tymon-Rosario; Gary Altwerger; Gulden Menderes; Anna Bianchi; Luca Zammataro; Aranzazu Manzano; Paola Manara; Elena Ratner; Dan-Arin Silasi; Gloria S Huang; Masoud Azodi; Peter E Schwartz; Francesco Raspagliesi; Roberto Angioli; Natalia Buza; Pei Hui; Heather M Bond; Alessandro D Santin
Journal:  Oncotarget       Date:  2020-02-04

8.  Prognostic molecular biomarkers in endometrial cancer: A review.

Authors:  J Edgardo Hernández; Ailyn González-Montiel; Jesús C Ceb Allos-Villalva; David Cantú; Salim Barquet; Anny Olivares-Mundo; Luis A Herrera; Diddier Prada
Journal:  J Cancer Res Ther (Manch)       Date:  2019-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.